NO851170L - Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer - Google Patents

Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer

Info

Publication number
NO851170L
NO851170L NO851170A NO851170A NO851170L NO 851170 L NO851170 L NO 851170L NO 851170 A NO851170 A NO 851170A NO 851170 A NO851170 A NO 851170A NO 851170 L NO851170 L NO 851170L
Authority
NO
Norway
Prior art keywords
destroying
pressures
quick
active substance
pharmaceutical active
Prior art date
Application number
NO851170A
Other languages
English (en)
Other versions
NO170125B (no
NO170125C (no
Inventor
Helmut Kopf
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NO851170L publication Critical patent/NO851170L/no
Publication of NO170125B publication Critical patent/NO170125B/no
Publication of NO170125C publication Critical patent/NO170125C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO851170A 1984-03-23 1985-03-22 Fremgangsmaate for fremstilling av lagringsstabile, hurtigopploeselige, farmasoeytiske virkestoff-presslegemer NO170125C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1465/84A CH658188A5 (de) 1984-03-23 1984-03-23 Lagerstabile schnellzerfallende pharmazeutische presslinge.

Publications (3)

Publication Number Publication Date
NO851170L true NO851170L (no) 1985-09-24
NO170125B NO170125B (no) 1992-06-09
NO170125C NO170125C (no) 1992-09-16

Family

ID=4211107

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851170A NO170125C (no) 1984-03-23 1985-03-22 Fremgangsmaate for fremstilling av lagringsstabile, hurtigopploeselige, farmasoeytiske virkestoff-presslegemer

Country Status (26)

Country Link
US (1) US4666703A (no)
JP (1) JPS60209518A (no)
AT (1) AT394310B (no)
AU (1) AU579355B2 (no)
BE (1) BE901994A (no)
CA (1) CA1239348A (no)
CH (1) CH658188A5 (no)
DE (1) DE3510129A1 (no)
DK (1) DK162375C (no)
ES (1) ES8702786A1 (no)
FI (1) FI82187C (no)
FR (1) FR2561524B1 (no)
GB (1) GB2157170B (no)
GR (1) GR850717B (no)
HK (1) HK73090A (no)
IE (1) IE57954B1 (no)
IL (1) IL74666A (no)
IT (1) IT1182723B (no)
LU (1) LU85817A1 (no)
NL (1) NL8500856A (no)
NO (1) NO170125C (no)
NZ (1) NZ211537A (no)
PT (1) PT80147B (no)
SE (1) SE8501370L (no)
SG (1) SG46890G (no)
ZA (1) ZA852160B (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
US4863743A (en) * 1985-02-19 1989-09-05 Key Pharmaceuticals, Inc. Controlled release potassium chloride
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
EP0462066A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphous gemfibrozil
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4317172A1 (de) * 1993-05-22 1995-01-05 Rhone Poulenc Rorer Gmbh Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
DE69633018T2 (de) * 1995-11-14 2004-12-09 Abbott Gmbh & Co. Kg Schilddrüsenhormone enthaltende stabilisierte arzneimittel und verfahren
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
AU2308097A (en) * 1996-04-26 1997-11-19 Shionogi & Co., Ltd. Rapid-release s1452 tablets
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
HU221435B (en) * 1998-02-20 2002-10-28 Egyt Gyogyszervegyeszeti Gyar Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
DK1276470T3 (da) 2000-04-20 2007-06-18 Novartis Ag Smagskaskerende overtrækssammensætning
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
MXPA03007337A (es) * 2001-02-15 2005-03-07 King Pharmaceuticals Inc Composicion farmaceutica y de hormona tiroidea estabilizada y metodo de preparacion de la misma.
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030171436A1 (en) * 2001-10-29 2003-09-11 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20050147666A1 (en) * 2002-03-06 2005-07-07 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
EP2101738A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
MX2009006699A (es) * 2006-12-21 2009-06-30 Mallinckrodt Inc Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos.
CN101380474B (zh) * 2007-09-06 2012-07-25 北京大学 用于口服制剂的pH敏感性固体药物组合物及制备方法
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
BE785702A (fr) * 1971-07-14 1972-10-16 Roehm Gmbh Produits de revetement de formes medicamenteuses et leur utilisation
GB1540754A (en) * 1976-03-10 1979-02-14 Wellcome Found Tablet formulation
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
CH642809B (fr) * 1980-11-07 Longines Montres Comp D Montre avec un mecanisme de quantieme perpetuel.
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta

Also Published As

Publication number Publication date
DK162375C (da) 1992-03-09
GR850717B (no) 1985-07-19
FI82187B (fi) 1990-10-31
AU4028785A (en) 1985-09-26
LU85817A1 (de) 1985-12-12
FI82187C (fi) 1991-02-11
NZ211537A (en) 1988-03-30
US4666703A (en) 1987-05-19
FI851114A0 (fi) 1985-03-20
ATA86885A (de) 1991-09-15
FI851114L (fi) 1985-09-24
CA1239348A (en) 1988-07-19
ZA852160B (en) 1985-11-27
DK162375B (da) 1991-10-21
AU579355B2 (en) 1988-11-24
IT8547844A1 (it) 1986-09-21
JPH0574568B2 (no) 1993-10-18
FR2561524B1 (fr) 1990-01-12
IL74666A0 (en) 1985-06-30
GB2157170A (en) 1985-10-23
SG46890G (en) 1990-08-17
ES8702786A1 (es) 1987-01-16
NO170125B (no) 1992-06-09
DK130685D0 (da) 1985-03-22
JPS60209518A (ja) 1985-10-22
IL74666A (en) 1988-11-30
IT1182723B (it) 1987-10-05
NL8500856A (nl) 1985-10-16
GB8506758D0 (en) 1985-04-17
ES541513A0 (es) 1987-01-16
PT80147A (en) 1985-04-01
BE901994A (fr) 1985-09-23
GB2157170B (en) 1988-01-20
IE57954B1 (en) 1993-05-19
SE8501370D0 (sv) 1985-03-20
PT80147B (pt) 1987-10-20
HK73090A (en) 1990-09-21
NO170125C (no) 1992-09-16
IT8547844A0 (it) 1985-03-21
SE8501370L (sv) 1985-09-24
AT394310B (de) 1992-03-10
CH658188A5 (de) 1986-10-31
FR2561524A1 (fr) 1985-09-27
DK130685A (da) 1985-09-24
IE850744L (en) 1985-09-23
DE3510129A1 (de) 1985-10-03

Similar Documents

Publication Publication Date Title
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
DK175487A (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
FI895821A0 (fi) Farmaceutiskt aktiva cns foereningar.
DE3853205D1 (de) Umhüllte Wirksubstanzen.
DK618186D0 (da) Konfektureindgiftssystem til aktive stoffer
DE3587577D1 (de) Antimykotische pharmazeutische Präparate.
DE3686626D1 (de) Speicherzelle.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
DE3580304D1 (de) Arzneimittel.
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
FI852512A0 (fi) Farmakologiskt aktiva substituerade benzamider.
FI882233A (fi) Farmakologiskt aktiva substituerade benzamider.
DE3577151D1 (de) Fehlertolerante speichermatrix.
FI875217A (fi) Aktivt pansar.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3687486D1 (de) Dynamische speicheranordnung.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
TR24383A (tr) Konsantre yuezey aktif madde granuelleri yapmaya mahsus yoentem
IT8521235A0 (it) Composti farmacologicamente attivi.
FI852658L (fi) Farmaceutiska aemnen.
FI860540A (fi) Gener foer biologiskt aktiva proteiner.
NO862560D0 (no) Biocide virkestoffkombinasjoner.
DE3881198D1 (de) Antiviraler wirkstoff.
FI883254A (fi) Cytostatiskt aktiva antracyklinderivat.